Arikayce

Insmed shares soar as PhIII lung disease study proves positive, pointing to quick FDA pitch
Endpoints
Tue, 09/5/17 - 10:16 pm
Insmed
clinical trials
Arikayce
ALIS
8 Biotech Events To Anticipate This Year: Part One
Seeking Alpha
Tue, 04/8/14 - 09:46 am
Zohydro
Zogenix
Zybrestat
Oxigene
Arikayce
Insmed
obeticholic acid
Intercept Pharmaceuticals